{"filing":{"accession_number":"0001628280-26-039233","cik":"0001516551","ticker":"SKYE","company_name":"Skye Bioscience, Inc.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"skye-20260526.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026039233/skye-20260526.htm"},"events":[{"id":8243,"run_id":7234,"accession_number":"0001628280-26-039233","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Skye Bioscience held its 2026 Annual Meeting of Stockholders on May 26, 2026, with shareholders voting on four proposals: election of six directors, ratification of CBIZ CPAs P.C. as auditor, approval of a Charter Amendment to increase authorized common shares from 100 million to 300 million, and advisory approval of named executive officer compensation. All proposals received final vote tallies disclosed in the filing.","company_name":"Skye Bioscience, Inc.","ticker":"SKYE","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2875,"accession_number":"0001628280-26-039233","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses an amendment to the Articles of Incorporation increasing authorized common shares from 100 million to 300 million, approved by stockholders at the May 26, 2026 Annual Meeting. While this is a charter amendment (Item 5.03), it does not fit neatly into the more specific event categories. The increase in authorized shares is material to investors as it expands the Company's capacity for future dilutive issuances, though the amendment itself is administrative rather than an immediate equity offering or capital event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:39:09.633547+00:00","company_name":"","ticker":null,"filing_date":""},{"id":2876,"accession_number":"0001628280-26-039233","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on May 26, 2026, covering four proposals: election of six directors, ratification of auditor (CBIZ CPAs P.C.), approval of a Charter Amendment, and advisory approval of named executive officer compensation. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 and constitutes material information affecting governance and corporate structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:39:09.633547+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2875,"accession_number":"0001628280-26-039233","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses an amendment to the Articles of Incorporation increasing authorized common shares from 100 million to 300 million, approved by stockholders at the May 26, 2026 Annual Meeting. While this is a charter amendment (Item 5.03), it does not fit neatly into the more specific event categories. The increase in authorized shares is material to investors as it expands the Company's capacity for future dilutive issuances, though the amendment itself is administrative rather than an immediate equity offering or capital event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:39:09.633547+00:00","company_name":"Skye Bioscience, Inc.","ticker":"SKYE","filing_date":"2026-05-29"},{"id":2876,"accession_number":"0001628280-26-039233","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on May 26, 2026, covering four proposals: election of six directors, ratification of auditor (CBIZ CPAs P.C.), approval of a Charter Amendment, and advisory approval of named executive officer compensation. The filing presents final vote tallies for each proposal, which is the core content of Item 5.07 and constitutes material information affecting governance and corporate structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:39:09.633547+00:00","company_name":"Skye Bioscience, Inc.","ticker":"SKYE","filing_date":"2026-05-29"}]}